NO973625L - Karbapenem-3-karboksylsyreesterderivater - Google Patents
Karbapenem-3-karboksylsyreesterderivaterInfo
- Publication number
- NO973625L NO973625L NO973625A NO973625A NO973625L NO 973625 L NO973625 L NO 973625L NO 973625 A NO973625 A NO 973625A NO 973625 A NO973625 A NO 973625A NO 973625 L NO973625 L NO 973625L
- Authority
- NO
- Norway
- Prior art keywords
- pct
- alkyl group
- carbapenem
- substituted
- carboxylic acid
- Prior art date
Links
- BSIMZHVOQZIAOY-SCSAIBSYSA-N 1-carbapenem-3-carboxylic acid Chemical compound OC(=O)C1=CC[C@@H]2CC(=O)N12 BSIMZHVOQZIAOY-SCSAIBSYSA-N 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP34507695 | 1995-12-08 | ||
| PCT/JP1996/003540 WO1997021712A1 (en) | 1995-12-08 | 1996-12-04 | Carbapenem-3-carboxylic acid ester derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO973625D0 NO973625D0 (no) | 1997-08-06 |
| NO973625L true NO973625L (no) | 1997-08-06 |
Family
ID=18374125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO973625A NO973625L (no) | 1995-12-08 | 1997-08-06 | Karbapenem-3-karboksylsyreesterderivater |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5886172A (de) |
| EP (1) | EP0808315B1 (de) |
| JP (1) | JP4667542B2 (de) |
| KR (1) | KR19980702089A (de) |
| AT (1) | ATE200289T1 (de) |
| AU (1) | AU705408B2 (de) |
| CA (1) | CA2211075A1 (de) |
| DE (1) | DE69612374T2 (de) |
| ES (1) | ES2156303T3 (de) |
| HU (1) | HUP9801156A3 (de) |
| IL (1) | IL121240A (de) |
| NO (1) | NO973625L (de) |
| TW (1) | TW420681B (de) |
| WO (1) | WO1997021712A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100345468B1 (ko) * | 2000-07-10 | 2002-07-26 | 한국과학기술연구원 | 신규 1-베타메틸카바페넴 유도체 및 그의 제조방법 |
| KR100446432B1 (ko) * | 2001-08-13 | 2004-08-30 | 한국화학연구원 | 2-벤조티아졸 카바페넴 유도체 및 그의 제조방법 |
| KR100451670B1 (ko) * | 2001-09-14 | 2004-10-08 | 한국화학연구원 | 내성균에 대해 항생작용을 갖는 카바페넴 유도체 및 이의제조방법 |
| AU2003301425A1 (en) * | 2002-10-18 | 2004-05-04 | Meiji Seika Kaisha, Ltd. | Process for producing carbapenem derivative and intermediate for use in the production |
| KR100599876B1 (ko) * | 2004-08-31 | 2006-07-13 | 한국화학연구원 | 2-아릴메틸아제티딘 카바페넴 유도체 및 그의 제조방법 |
| CN101868460A (zh) * | 2007-11-23 | 2010-10-20 | 国际药品工业株式会社 | 2-芳基甲基吖丁啶-碳青霉烯-3-羧酸酯衍生物或其盐、其制备方法以及包含上述的药物组合物 |
| US8394922B2 (en) | 2009-08-03 | 2013-03-12 | Medarex, Inc. | Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
| CN102532139A (zh) * | 2010-12-07 | 2012-07-04 | 重庆医药工业研究院有限责任公司 | 一种替比培南的制备方法 |
| CN102558181B (zh) * | 2010-12-15 | 2015-04-22 | 石药集团中奇制药技术（石家庄）有限公司 | 一种碳青霉烯抗生素的制备方法 |
| CN102731507B (zh) * | 2011-04-13 | 2015-04-01 | 石药集团中奇制药技术（石家庄）有限公司 | 泰比培南晶型、其制备方法及其在制备药物中的应用 |
| CN102757430B (zh) * | 2011-04-29 | 2016-04-13 | 上海医药工业研究院 | 一种替比培南的制备方法 |
| CN102775409B (zh) * | 2011-05-10 | 2016-08-03 | 上海医药工业研究院 | 一种替比培南匹伏酯的中间体的制备方法 |
| CN102584812B (zh) * | 2011-11-18 | 2014-03-12 | 深圳万乐药业有限公司 | 一种泰比培南酯杂质的制备方法 |
| CN102503940B (zh) * | 2011-11-22 | 2013-12-25 | 深圳万乐药业有限公司 | 制备泰比培南酯开环杂质的方法 |
| LT2956173T (lt) | 2013-02-14 | 2017-06-26 | Bristol-Myers Squibb Company | Tubulizino junginiai, gavimo ir panaudojimo būdai |
| US10077287B2 (en) | 2014-11-10 | 2018-09-18 | Bristol-Myers Squibb Company | Tubulysin analogs and methods of making and use |
| ES3037252T3 (en) | 2016-12-15 | 2025-09-30 | Spero Therapeutics Inc | Novel tebipenem pivoxil immediate and modified release oral dosage forms |
| PL3577119T3 (pl) | 2017-02-06 | 2026-03-23 | Spero Therapeutics, Inc. | Postacie krystaliczne tebipenemu piwoksylu, zawierające je kompozycje, sposoby wytwarzania i sposoby zastosowania |
| WO2022104087A1 (en) | 2020-11-11 | 2022-05-19 | Spero Therapeutics, Inc. | High dosage tebipenem pivoxil tablet formulation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60202886A (ja) * | 1984-03-27 | 1985-10-14 | Sankyo Co Ltd | １―置換カルバペネム―３―カルボン酸誘導体 |
| EP0597821A1 (de) * | 1988-04-01 | 1994-05-18 | Sankyo Company Limited | 2-(Heterocyclylthio) carbapenemderivate, deren Herstellung und Verwendung als Antibiotika |
| JPH06157532A (ja) * | 1992-11-17 | 1994-06-03 | Sankyo Co Ltd | 結晶性カルバペネム化合物 |
| AU682510B2 (en) * | 1993-07-01 | 1997-10-09 | Pfizer Japan Inc. | 2-(1-(1,3-thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivatives |
| JP3317604B2 (ja) * | 1994-12-28 | 2002-08-26 | 日本ワイスレダリー株式会社 | 結晶形態のカルバペネム化合物 |
-
1996
- 1996-12-02 TW TW085114853A patent/TW420681B/zh active
- 1996-12-04 AT AT96941156T patent/ATE200289T1/de active
- 1996-12-04 ES ES96941156T patent/ES2156303T3/es not_active Expired - Lifetime
- 1996-12-04 WO PCT/JP1996/003540 patent/WO1997021712A1/en not_active Ceased
- 1996-12-04 KR KR1019970705484A patent/KR19980702089A/ko not_active Abandoned
- 1996-12-04 CA CA002211075A patent/CA2211075A1/en not_active Abandoned
- 1996-12-04 HU HU9801156A patent/HUP9801156A3/hu unknown
- 1996-12-04 JP JP52191797A patent/JP4667542B2/ja not_active Expired - Fee Related
- 1996-12-04 DE DE69612374T patent/DE69612374T2/de not_active Expired - Fee Related
- 1996-12-04 EP EP96941156A patent/EP0808315B1/de not_active Expired - Lifetime
- 1996-12-04 US US08/875,131 patent/US5886172A/en not_active Expired - Lifetime
- 1996-12-04 IL IL12124096A patent/IL121240A/en not_active IP Right Cessation
- 1996-12-04 AU AU10399/97A patent/AU705408B2/en not_active Ceased
-
1997
- 1997-08-06 NO NO973625A patent/NO973625L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11504039A (ja) | 1999-04-06 |
| IL121240A0 (en) | 1998-01-04 |
| NO973625D0 (no) | 1997-08-06 |
| IL121240A (en) | 2001-08-08 |
| ES2156303T3 (es) | 2001-06-16 |
| EP0808315A1 (de) | 1997-11-26 |
| AU1039997A (en) | 1997-07-03 |
| US5886172A (en) | 1999-03-23 |
| DE69612374D1 (de) | 2001-05-10 |
| EP0808315B1 (de) | 2001-04-04 |
| DE69612374T2 (de) | 2001-07-12 |
| ATE200289T1 (de) | 2001-04-15 |
| HUP9801156A2 (hu) | 1998-09-28 |
| AU705408B2 (en) | 1999-05-20 |
| JP4667542B2 (ja) | 2011-04-13 |
| HUP9801156A3 (en) | 1999-03-01 |
| TW420681B (en) | 2001-02-01 |
| KR19980702089A (ko) | 1998-07-15 |
| CA2211075A1 (en) | 1997-06-19 |
| WO1997021712A1 (en) | 1997-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO973625L (no) | Karbapenem-3-karboksylsyreesterderivater | |
| EP0865281A4 (de) | Naphthyl substituierte benzimidazolderivate als antikoagulantien | |
| CA2041168A1 (en) | Use of alkylcarboxylic acid dimethylamides as crystallization inhibitors | |
| IE861820L (en) | 2-hydroxy-2-phenylethylaminotetralines | |
| TW265337B (de) | ||
| AU2534288A (en) | Heterocyclic compounds | |
| CA2103590A1 (en) | Benzamide derivative | |
| TW263513B (de) | ||
| ATE181333T1 (de) | Azirdin-derivate, deren herstellung und verwendung | |
| AU541413B2 (en) | 2-(1,4-benzodioxan-2-ylalicyl)imidazoles | |
| DE69624121D1 (de) | Membranen possierende second messengers | |
| DK0601345T3 (da) | Lægemiddel Indeholdende en imidazol-l-yl-forbindelse | |
| AU3809095A (en) | 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives | |
| GB9906192D0 (en) | Photoreleasable compounds | |
| ATE110569T1 (de) | Pharmazeutische zusammensetzung zur verbesserung von dysuria. | |
| ES2020012A6 (es) | Procedimiento para la obtencion de un preparado farmaceutico antimicrobiano de uso topico. | |
| IL105122A0 (en) | Benzimidazole derivative for use as an anti-irritant | |
| AU551901B2 (en) | Substituted thienobenzodiazepinones | |
| IT1268414B1 (it) | Enantiomeri farmacologicamente attivi | |
| ES2038389T3 (es) | Procedimiento para la obtencion de 3-aminosidnoniminas substituidas farmacologicamente activas. | |
| WO1999050252A3 (en) | Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same | |
| AU4544096A (en) | New derivatives of glycylanilides, preparation and therapeutical application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |